GSK

News

GSK grows pipeline with 35Pharma takeover, Frontier deal

GSK CEO Luke Miels signs a pair of pipeline-expanding deals, and the first acquisition on his watch, as the group prepares for a looming patent cliff.

News

EU approval for new asthma drug Exdensur lifts GSK

EU approval takes GSK a step closer to fulfilling its blockbuster sales hopes for new long-acting respiratory drug Exdensur.

News

GSK delivers in new CEO Miels' first financial update

Luke Miels' first financial results since taking over as chief executive of GSK revealed a jump in sales and profits.

News

GSK departs Wave's AATD programme

Wave Life Sciences has lost GSK as the partner for its alpha-1 antitrypsin deficiency drug, but other partnered RNA-editing programmes remain active.

News

CMS's Medicare price negotiations start round three

The US federal government has named the next 15 big-selling medicines that will be subject to Medicare pricing negotiations.

News

Man looking through red lenses of binoculars

11 high-impact drugs to look out for in 2026

Medicines for obesity, diabetes, rare diseases, cancer, and women's health feature among Clarivate's annual round-up of 11 Drugs to Watch this year.

GSK grows pipeline with 35Pharma takeover, Frontier deal

EU approval for new asthma drug Exdensur lifts GSK

GSK delivers in new CEO Miels' first financial update

GSK departs Wave's AATD programme

CMS's Medicare price negotiations start round three

11 high-impact drugs to look out for in 2026

NHS "isn't delivering equitable care for rare diseases"

Using AI-driven synthetic personas to take your insights fur...

GSK

Editor's Picks